Laboratorios Farmaceuticos Rovi, S.A. (BIT:1ROVI)
53.15
+1.05 (2.02%)
At close: May 9, 2025
BIT:1ROVI Revenue
Laboratorios Farmaceuticos Rovi had revenue of 154.89M EUR in the quarter ending March 31, 2025, with 2.46% growth. This brings the company's revenue in the last twelve months to 767.47M, down -1.49% year-over-year. In the year 2024, Laboratorios Farmaceuticos Rovi had annual revenue of 763.75M, down -7.93%.
Revenue (ttm)
767.47M
Revenue Growth
-1.49%
P/S Ratio
3.60
Revenue / Employee
349.32K
Employees
2,197
Market Cap
2.76B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 763.75M | -65.76M | -7.93% |
Dec 31, 2023 | 829.51M | 11.81M | 1.44% |
Dec 31, 2022 | 817.70M | 169.02M | 26.06% |
Dec 31, 2021 | 648.68M | 228.72M | 54.46% |
Dec 31, 2020 | 419.96M | 38.65M | 10.14% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Intesa Sanpaolo | 25.42B |
UniCredit | 23.99B |
Enel SpA | 78.35B |
Ferrari | 6.88B |
Assicurazioni Generali | 55.30B |
Eni S.p.A. | 90.96B |
Leonardo S.p.a. | 18.26B |
Stellantis | 156.88B |